News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Ixazomib dexamethasone a new treatment in the arsenal against RRMM
18 Feb 2022
In heavily pretreated, lenalidomide-refractory patients with relapsed-refractory multiple myeloma (RRMM) and prior exposure to proteasome inhibitors, ixazomib dexamethasone may be an effective and tolerable treatment approach, leading to comparable health-related quality of life outcomes as pomalidomide-dexamethasone, a recent study has found.
18 Feb 2022

Being physically active helps prevent NAFLD
18 Feb 2022
byStephen Padilla
Physical activity (PA) is associated with a lower prevalence of nonalcoholic fatty liver disease (NAFLD), with greater benefits for higher PA intensities, reveals a study. Better metabolic health, particularly lower waist circumference and insulin resistance, mediates this association.
18 Feb 2022






